دورية أكاديمية

Residual Pain in the Context of Selecting and Switching Biologic Therapy in Inflammatory Rheumatic Diseases

التفاصيل البيبلوغرافية
العنوان: Residual Pain in the Context of Selecting and Switching Biologic Therapy in Inflammatory Rheumatic Diseases
المؤلفون: Berghea, Florian, Berghea, Camelia Elena, Zaharia, Dumitru, Trandafir, Andreea Iulia, Nita, Elena Cristina, Vlad, Violeta Maria
المصدر: Frontiers in Medicine ; volume 8 ; ISSN 2296-858X
بيانات النشر: Frontiers Media SA
سنة النشر: 2021
المجموعة: Frontiers (Publisher - via CrossRef)
الوصف: For many years, inflammatory rheumatic diseases (IRDs) represented a source of disappointment in medical care caused by the mediocre efficacy of the available treatments. Some of these diseases, like Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS), caused fear in the general population, especially due to associated joint deformities and subsequent disabilities. However, in the last 20 years, a new successful class of antirheumatic drugs has become available: biologic Disease-Modifying Antirheumatic Drugs (bDMARDs). Due to this innovative treatment, the days are over when joint and spine deformities defined the condition of a person with RA or AS. Nonetheless, expectations are higher today, and other clinical problems, (not entirely solved by bDMARDs), seem to drive the drug selection during the span of rheumatic diseases. Most of these issues are covered by the term “unmet needs.” One of the most intriguing of such needs is the residual pain (RP) in patients that are otherwise in the biological remission of the disease. Present in a significant proportion of the patients that enter remission status, RP is poorly understood and managed. In recent years, new data has become available in this area and new conceptual clarifications have occurred. In this review, we explain the various nature of RP and the necessity of treatment diversification in such situations. All in all, we believe this condition is far more complex than simple pain and includes other clinical aspects, too (like fatigue or mood changes) so the terms Post-Remission Syndrome (PRS), and PRS pain might be more appropriate.
نوع الوثيقة: article in journal/newspaper
اللغة: unknown
DOI: 10.3389/fmed.2021.712645
DOI: 10.3389/fmed.2021.712645/full
الإتاحة: https://doi.org/10.3389/fmed.2021.712645Test
حقوق: https://creativecommons.org/licenses/by/4.0Test/
رقم الانضمام: edsbas.53EF9B9F
قاعدة البيانات: BASE